Clinical response to isotretinoin and interferon-α of two dogs with cutaneous epitheliotropic T-cell lymphoma: a case report
- PMID: 30514314
- PMCID: PMC6278019
- DOI: 10.1186/s12917-018-1710-y
Clinical response to isotretinoin and interferon-α of two dogs with cutaneous epitheliotropic T-cell lymphoma: a case report
Abstract
Background: There is no specific therapy for cutaneous epitheliotropic T-cell lymphoma (CETL). The administration of retinoids in conjunction with interferon-α (IFN-α) in CETL has not been reported in dogs.
Case presentation: Two dogs (Shih tzu and Miniature pinscher) presented with multiple nodular skin lesions. Histopathological examination revealed diffuse infiltrations of lymphocytes in the epidermis and dermis, with a CD3-positive immunophenotypic profile. Based on the clinical and histopathological examination, CETL was diagnosed. Both dogs were treated with isotretinoin in combination with IFN-α and showed clinical improvement with complete or partial remission. The disease in these dogs was well-controlled for more than 264 days of overall median survival time without any additional clinical signs after initiation of the treatment. In both the cases, the dogs were followed up for 27 months, and 10 months without any evidence of recurrence or metastasis, respectively.
Conclusions: We describe the clinical efficacy of isotretinoin combined with IFN-α in 2 dogs with CETL. Long-term management with isotretinoin combined with IFN-α was effective in treating CETL in these cases.
Keywords: Canine; Cutaneous T-cell lymphoma; Interferon-α; Retinoids.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent to publication
Written consent was obtained from the present owners of the dogs for publication of this case report and any accompanying images.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures




Similar articles
-
Cutaneous epitheliotropic T-cell lymphoma with systemic dissemination in a dog.J Vet Diagn Invest. 2016 May;28(3):327-31. doi: 10.1177/1040638716637642. Epub 2016 Mar 7. J Vet Diagn Invest. 2016. PMID: 26951331
-
Efficacy of verdinexor for the treatment of naïve canine epitheliotropic cutaneous T-cell lymphoma: An open-label pilot study.Vet Dermatol. 2024 Oct;35(5):536-546. doi: 10.1111/vde.13280. Epub 2024 Jul 29. Vet Dermatol. 2024. PMID: 39074816
-
Treatment of canine cutaneous epitheliotropic T-cell lymphoma with oclacitinib: a case report.Vet Dermatol. 2021 Aug;32(4):398-e113. doi: 10.1111/vde.12976. Epub 2021 May 25. Vet Dermatol. 2021. PMID: 34033147
-
Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topic.BMC Vet Res. 2017 Feb 21;13(1):61. doi: 10.1186/s12917-017-0978-7. BMC Vet Res. 2017. PMID: 28222789 Free PMC article. Review.
-
Canine cutaneous epitheliotropic T-cell lymphoma: a review.Vet Comp Oncol. 2009 Mar;7(1):1-14. doi: 10.1111/j.1476-5829.2008.00176.x. Vet Comp Oncol. 2009. PMID: 19222826 Review.
Cited by
-
Cutaneous lymphoma in a Dachshund.Can Vet J. 2021 Jul;62(7):771-774. Can Vet J. 2021. PMID: 34219791 Free PMC article. No abstract available.
-
Comparison of the pathogenicity of porcine reproductive and respiratory syndrome virus (PRRSV)-1 and PRRSV-2 in pregnant sows.Arch Virol. 2022 Feb;167(2):425-439. doi: 10.1007/s00705-021-05303-8. Epub 2022 Jan 26. Arch Virol. 2022. PMID: 35079900
References
-
- Kshma MA, Yathiraj S, Rao S. Therapeutic Management of Cutaneous Lymphoma in a dog. Intas Polivet. 2013;14:477–478.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources